|
|
||||||||
CUTTING EDGE |


* Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322; and
Department of Microbiology, University of Virginia Health Sciences Center, Charlottesville, VA 22908
The mechanism by which antagonist peptides inhibit T cell responses is unknown. Mice deficient in Src homology 2 domain-containing protein tyrosine phosphatase (SHP-1) have revealed its importance in the negative regulation of lymphocyte signaling. We investigated a possible role for SHP-1 in T cell antagonism and demonstrate, for the first time, a substantial increase in SHP-1 activity during antagonism of CD4+ T cells. Furthermore, the removal of functional SHP-1 prevents antagonism in these cells. Our data demonstrate that T cell antagonism occurs via a negative intracellular signal that is mediated by SHP-1.
This article has been cited by other articles:
![]() |
D. S. Jones, P. Reichardt, M. L. Ford, L. J. Edwards, and B. D. Evavold TCR Antagonism by Peptide Requires High TCR Expression J. Immunol., August 1, 2008; 181(3): 1760 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Monu and A. B. Frey Suppression of Proximal T Cell Receptor Signaling and Lytic Function in CD8+ Tumor-Infiltrating T Cells Cancer Res., December 1, 2007; 67(23): 11447 - 11454. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Haribhai, B. Edwards, M. L. Williams, and C. B. Williams Functional Reprogramming of the Primary Immune Response by T Cell Receptor Antagonism J. Exp. Med., December 6, 2004; 200(11): 1371 - 1382. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |